REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 204 filers reported holding REPLIGEN CORP in Q3 2018. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,811,539 | -69.6% | 55,415 | -73.0% | 0.00% | -83.3% |
| Q2 2023 | $28,995,339 | -4.6% | 204,972 | +13.5% | 0.01% | -14.3% |
| Q1 2023 | $30,403,796 | +59.1% | 180,588 | +60.0% | 0.01% | +40.0% |
| Q4 2022 | $19,109,681 | -33.0% | 112,868 | -26.0% | 0.01% | -37.5% |
| Q3 2022 | $28,524,000 | -3.9% | 152,444 | -16.6% | 0.01% | +14.3% |
| Q2 2022 | $29,682,000 | -27.4% | 182,772 | -16.0% | 0.01% | +16.7% |
| Q1 2022 | $40,905,000 | -33.9% | 217,477 | -6.9% | 0.01% | +200.0% |
| Q4 2021 | $61,890,000 | -4.2% | 233,686 | +4.6% | 0.00% | -75.0% |
| Q3 2021 | $64,583,000 | +114.6% | 223,479 | +48.3% | 0.01% | +100.0% |
| Q2 2021 | $30,090,000 | -35.9% | 150,736 | -37.6% | 0.00% | -50.0% |
| Q1 2021 | $46,930,000 | -45.6% | 241,401 | -46.4% | 0.01% | +14.3% |
| Q4 2020 | $86,240,000 | +174.0% | 450,034 | +111.0% | 0.01% | +40.0% |
| Q3 2020 | $31,470,000 | +54.5% | 213,297 | +29.4% | 0.01% | 0.0% |
| Q2 2020 | $20,372,000 | +32.6% | 164,802 | +3.6% | 0.01% | 0.0% |
| Q1 2020 | $15,364,000 | -31.5% | 159,145 | -34.3% | 0.01% | -16.7% |
| Q4 2019 | $22,413,000 | -40.6% | 242,291 | -50.8% | 0.01% | -53.8% |
| Q3 2019 | $37,745,000 | -63.7% | 492,167 | -59.3% | 0.01% | 0.0% |
| Q2 2019 | $103,996,000 | +607.8% | 1,209,928 | +386.5% | 0.01% | +116.7% |
| Q1 2019 | $14,693,000 | +154.8% | 248,700 | +127.4% | 0.01% | +100.0% |
| Q4 2018 | $5,767,000 | +6.7% | 109,362 | +12.2% | 0.00% | +50.0% |
| Q3 2018 | $5,407,000 | +1.4% | 97,500 | -13.9% | 0.00% | 0.0% |
| Q2 2018 | $5,330,000 | -20.5% | 113,300 | -38.9% | 0.00% | 0.0% |
| Q1 2018 | $6,704,000 | -5.9% | 185,300 | -5.6% | 0.00% | 0.0% |
| Q4 2017 | $7,121,000 | +0.1% | 196,300 | +5.7% | 0.00% | -33.3% |
| Q3 2017 | $7,116,000 | -7.5% | 185,700 | +0.0% | 0.00% | 0.0% |
| Q2 2017 | $7,693,000 | +117.4% | 185,637 | +84.7% | 0.00% | +50.0% |
| Q1 2017 | $3,538,000 | -45.7% | 100,500 | -52.5% | 0.00% | -33.3% |
| Q4 2016 | $6,519,000 | +168.5% | 211,500 | +163.1% | 0.00% | +50.0% |
| Q3 2016 | $2,428,000 | -42.4% | 80,400 | -47.8% | 0.00% | -33.3% |
| Q2 2016 | $4,216,000 | -61.2% | 154,100 | -62.0% | 0.00% | -50.0% |
| Q1 2016 | $10,862,000 | -8.9% | 405,000 | -3.9% | 0.01% | +20.0% |
| Q4 2015 | $11,920,000 | +354.3% | 421,347 | +347.2% | 0.01% | – |
| Q3 2015 | $2,624,000 | +14.3% | 94,229 | +69.3% | 0.00% | -100.0% |
| Q2 2015 | $2,296,000 | +114.8% | 55,642 | +58.1% | 0.00% | – |
| Q1 2015 | $1,069,000 | -72.0% | 35,200 | -81.8% | 0.00% | -100.0% |
| Q4 2014 | $3,824,000 | -51.1% | 193,143 | -50.9% | 0.00% | -33.3% |
| Q3 2014 | $7,827,000 | +52.5% | 393,100 | +74.6% | 0.00% | +50.0% |
| Q2 2014 | $5,132,000 | +275.1% | 225,186 | +111.6% | 0.00% | +100.0% |
| Q1 2014 | $1,368,000 | -22.7% | 106,400 | -18.0% | 0.00% | 0.0% |
| Q4 2013 | $1,769,000 | -53.6% | 129,700 | -62.3% | 0.00% | 0.0% |
| Q3 2013 | $3,813,000 | +760.7% | 343,799 | +539.0% | 0.00% | – |
| Q2 2013 | $443,000 | – | 53,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |